Phase 3
Completed N=243
Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging
Source: ClinicalTrials.gov NCT01287377 ↗Enrolled (actual)
243
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcomePrimary: Number of Participants Who Have Not Used Tobacco in the Past 30 Days — 18; 26; 10 Participants
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The primary purpose of this study is to test the feasibility of sending pre-cessation nicotine patches and to examine the effects associated with the pre-cessation treatment phase. Specifically, this study aims to:
1. See if subjects will use pre-cessation nicotine patches.
2. See if subjects in the pre-cessation nicotine patches go on to get more nicotine patches.
3. See if pre-cessation treatment with nicotine patches leads to a decrease in number of cigarettes smoked per day.
4. See if sending 2-weeks' worth of patches is helpful to the quitting process.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Have Not Used Tobacco in the Past 30 Days |
18; 26; 10 | — |
| SECONDARY Number of Participants With Serious Quit Attempts |
48; 53; 42 | — |
Eligibility Criteria
Inclusion Criteria
- >= 18 years old
- Daily smoker
- >=10 cigarettes per day
- Ready to quit within one month
- First time quitline caller
- Valid phone number
- Valid address (no P.O. boxes)
- California resident
- Agree to participate in study and evaluation
- English speaking
Exclusion Criteria
- Uses other form of tobacco
- Plan to use quitting aids other than nicotine patch
- Has any of the following conditions:
- Severe allergy to adhesive tape
- Arrhythmia
- Angina
- Heart attack within last 6 months
- Stroke within last 6 months
- Uncontrolled high blood pressure
- Insulin-dependent diabetes
- Pregnancy
Data sourced from ClinicalTrials.gov (NCT01287377). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.